LOUIS DURANTE: Open Payments
NPI 1720798812 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,254 in 102 payments from 19 companies in 2025. Trend: 2023 $221 · 2024 $1,947 · 2025 $2,254
Food & beverage: $2,254
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $577 |
| Janssen Biotech, Inc. | 7 | $263 |
| Madrigal Pharmaceuticals | 11 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $235 |
| GENZYME CORPORATION | 9 | $187 |
| Ipsen Biopharmaceuticals, Inc | 4 | $135 |
| Ardelyx, Inc. | 6 | $112 |
| Lilly USA, LLC | 3 | $103 |
| Intercept Pharmaceuticals, Inc. | 4 | $70 |
| Novo Nordisk Inc | 4 | $65 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, DUPIXENT, SKYRIZI, IQIRVO, ENTYVIO, IBSRELA.
Industry payments across UT — which companies pay providers there.
